List of top 200 securities held by Lion Point Capital LP:
- Institutional investors with $100 million or more in holdings are required to report their portfolio holdings on a quarterly basis within 45 days of the end of a calendar quarter.
- The table below lists top 200 holdings for the reported quarter.
- Portfolio values with missing quarterly reports are assigned zero.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Quarter: 2024Q4
Report Date Time: 2025-02-14 08:54:53
Total Holdings: 19
Assets Under Management (AUM) :
$19,099,206 ($19.099M)
Reporting Manager: Irshad Karim
Address:
375 PARK AVE
SUITE 2609
NEW YORK, NY 10152
Since 2015-12-31: total money flow = -$1.239B, gains and losses = $970.92M
| 1 | INSMED INC- INSM | 2024Q4 | 36,700 | $2.534M ($69.04) | 13.27% |  | | History |
| 2 | MILESTONE PHARMACEUTICALS INC MIST | 2024Q4 | 1,025,806 | $2.421M ($2.36) | 12.68% | | | History |
| 3 | GERON CORP GERN | 2024Q4 | 500,000 | $1.77M ($3.54) | 9.27% | | | History |
| 4 | ARDELYX INC ARDX | 2024Q4 | 335,400 | $1.70M ($5.07) | 8.90% | | | History |
| 5 | FENNEC PHARMACEUTICALS, INC. O FENC | 2024Q4 | 195,700 | $1.237M ($6.32) | 6.48% | | | History |
| 6 | BRIDGEBIO PHARMA INC BBIO | 2024Q4 | 40,300 | $1.106M ($27.44) | 5.79% | | | History |
| 7 | MINERALYS THERAPEUTICS INC MLYS | 2024Q4 | 79,000 | $972.49K ($12.31) | 5.09% | | | History |
| 8 | KINIKSA PHARMACEUTICALS INTL P KNSA | 2024Q4 | 45,900 | $907.902K ($19.78) | 4.75% | | | History |
| 9 | BIOHAVEN RESH LTD. USD COM SHS BHVN | 2024Q4 | 22,700 | $847.845K ($37.35) | 4.44% | | | History |
| 10 | BENITEC BIOPHARMA INC BNTC | 2024Q4 | 62,000 | $783.06K ($12.63) | 4.10% | | | History |
Showing 1 to 10 of 19 entries
×